Au clusters |
Two-photon absorption |
Improving light penetration |
[22,31,32] |
ZnTPyP@TiO2 nanocomposites |
Two-photon absorption |
Improving light penetration |
[33] |
CaWO4 NPs, SrAl2O4:Eu2+ NPs and Cu NPs |
X-ray-triggered persistent luminescence |
Overcoming light penetration |
[48,49,50] |
ZnGa2O4:Cr |
Persistent luminescence |
Internal light in tumor site |
[41,42,43,44] |
Luciferase-exposed PLGA NPs |
Bioluminescence |
Internal light in tumor site |
[40] |
SPION |
MR imaging and magnetic targeting |
Imaging-guided PDT |
[117,118,119,120,121] |
Holmium(III)/iridium(III) bimetallic complex NPs |
US imaging |
Imaging-guided PDT |
[128] |
Zn-porphyrin-based nanoassemblies |
NO release |
NO-involved sensitized PDT |
[155] |
CORM-loaded FADP nanocarriers |
CO release |
Killing bacteria and ablation of biofilms |
[152] |
GOx-modified HMSNs |
Decomposition of glucose |
Starvation therapy |
[148,149] |
N-doped carbon-silica nanocomposites |
Immunoadjuvant properties |
Enhancing immunogenicity |
[143] |
TF-exposed RBC membrane-coated PLGA NPs |
Targeting to TF receptor-overexpressed cancer cells |
Enhancing PS concentration |
[116] |
Gemini iridium(III) complex-based nanovesicles |
Mitochondria targeting |
Enhancing PSs concentration |
[104] |
PpIX-conjugated peptide NPs |
Plasma membrane targeting |
Enhancing PSs concentration |
[98] |
Fe3O4@m-MnO2 NPs |
Oxygen modulation and magnetic targeting |
Hypoxia relief in TME |
[83] |
Carbon nitride (C3N4) |
Water-splitting |
Hypoxia relief in TME |
[87] |
V2O5 NPs |
Peroxidase-like activity |
Hypoxia relief in TME |
[80] |
pH-sensitive PFC-modified nanoparticles |
Loading oxygen |
Hypoxia relief in TME |
[69] |